Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

GPs in England say they lack confidence in initially assessing and referring people with neurological symptoms, especially those with multiple sclerosis, and believe they could benefit from better...

A cell therapy product derived from human umbilical cord blood cells may be a promising treatment approach for patients with demyelinating conditions, such as multiple sclerosis (MS) or...

The further away you live from the equator, apparently the more likely you are to be diagnosed with MS. It sounds simple...

Researchers from Colorado State University have proposed a new model of fatigue in multiple sclerosis which is...

Using a gaming camera that detects movement and computer algorithms that quantify people's walking patterns could help clinicians objectively monitor the differences in gait of multiple sclerosis...

People living with multiple sclerosis in Wales are "lagging behind" the rest of the UK in access to treatments, it has been claimed.

The MS Society found 49 per cent of 575 Welsh people...

Scientists at Stanford University School of Medicine have developed a method for stem cell transplants that may do away with the need for prior systematic treatment with chemotherapy or...

Though approved therapies for multiple sclerosis (MS) exist, the condition remains incurable leading to greater interest...

A large study of multiple sclerosis patients has concluded clinical and brain imaging assessments drawn from magnetic resonance imaging (MRI) scans are poor measures of long-term prognosis for...

New research from the University of Dundee, and funded by Arthritis Research UK and the MRC, has shown that targeting a specific group of enzymes could be a viable strategy for treating autoimmune...

Pages